Sentences with phrase «company at the best price»

Warren Buffett has proven that buying great companies at good prices and holding them for as long as possible can lead to amazing returns.
The trick is finding great companies at good prices.
Given that Berkshire nowadays focuses on buying great companies at a good price, it's interesting to see them continuing to buy shares even while DVA approaches 52 - week highs.
Others, like Allworth, downplay geography, preferring to focus on finding «good companies at good prices» that provide a balance of sectors.
If you purchased a high quality company at a good price, you will benefit from this.
If you can buy a dividend growth company at a better price, you are rewarded with a higher yield.
However, because many dividend investors devote so much time and enthusiasm to identifying great companies at good prices, they mistakenly believe that this is the essence of the strategy.
Greenblatt's formula is intended to buy good companies at good prices.
The project yielded some great insight into Joel Greenblatt's «Magic Formula» — a simple process for buying good companies at good prices — and into how strategies for buying companies at pessimistic prices perform when price - to - earnings multiples contract.
Joel Greenblatt, a prominent member of the «buy good companies at good prices» school of investing, shared the following observations in a September 2015 note to investors [1]:
Also, I think your focus is the best way to invest — buying your preferred companies at the best prices.
I need to spread things out a bit but right now I'm just focused on collecting my favorite companies at good prices.
If you work for a company that does have stock, your employer may offer you a «deal» to purchase stock in the company at a good price.
Volatility like we have been seeing is an opportunity to acquire high quality companies at good prices.
Naturally, prudent stock - picking is implied here, and this Brexit aftermath is best treated as an ideal opportunity to upgrade to higher quality / growth companies at a better price.
In the end, the safest way of anticipating & playing out this potential scenario is (again) to upgrade one's portfolio to focus on higher quality / growth companies at a better price — i.e. companies which can ideally offer stability & secular growth, regardless of the economic environment & outlook.
I didn't know to buy great companies at good prices until I had 10 years of investing experience.
Like Buffett I would rather own pieces of great companies at a good price then good companies at a great price.
There are, in general, two flavors of value investing: buy cigar butts on the cheap (wretched companies whose stocks more than discount their misery) or buy great companies at good prices.
Everyone talks about some combination of 1) owning part share in a quality business, 2) buying good companies at good prices, 3) finding moats, 4) insisting on discounts / margins of safety, and 5) making contrarian bets (buying stocks under duress).
When you apply for life insurance with us we make sure we are placing you with the best company at the best price for you, based on your unique health and lifestyle.
We are here to help you shop for the right company at the best price possible.
We are comprised of seasoned life insurance professionals whose primary objective is to find our clients the best company at the best price.
Our # 1 priority is to find you the best company at the best price... for you!
We are not bound to any one company which provides us with the freedom to align our clients with the best type of life insurance, along with the best company at the best price based on each individual client's unique health and lifestyle.
Our job is to find you the best company at the best price... for you!
This allows us to tailor a policy to each client's individual need so that we place that client with the best company at the best price for that specific client.
That way you can guarantee you are getting the best company at the best price.
Our job is to find you the best company at the best price — for you!
Our goal is to find the best company at the best price for your unique situation.
We are an agency focused on aligning the best company at the best price with each individual client's needs.
We will help you find the best company at the best price — for you, based on your unique health and lifestyle.
We will be able to ask a few pointed questions on your health and lifestyle that will help us direct you to the best company at the best price.
We specialize in finding the best company at the best price — for you, based on your unique health and lifestyle.
Therefore, don't just settle on this one company but let us direct you to the best company at the best price for your specific scenario.
By working with multiple carriers, we give the consumer the power to choose the best life insurance company at the best price.
Basically, we shop the front end and back end of the life insurance process to make sure you are getting the best company at the best price!
This allows us to guarantee you are getting the best company at the best price.
If you need an instant issue life insurance policy we can help steer you to the best company at the best price based on your unique circumstances.
We are an agency that specializes in finding the best company at the best price — for you!
We work with the best life insurance companies in the U.S. Let us help you find the best company at the best price — for you!
In this way you can be sure that you are getting the best company at the best price — for you.
TermLife2Go works with all the top companies so we can shop around for you and make sure we are offering the best company at the best price.
Finding the best company at the best price requires choices.
Our goal is to find the best company at the best price — for you!
Options are the key to finding the best company at the best price which is why we stress the importance of knowing how to buy final expense insurance.
That means we are experts in finding our clients the best company at the best price based on the client's specific health or lifestyle profile.

Not exact matches

Combine that with weak commodity prices, flat global trade and the governance risk associated with companies in many of these countries, and safety - minded investors are perhaps best served by limiting their exposure to the grouping at this time.
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Nearly as surprising was the willingness of Russia and private oil companies in North America to carry on at prices that were understood to be well below their break - even points.
a b c d e f g h i j k l m n o p q r s t u v w x y z